S R Earnshaw

Summary

Affiliation: RTI International
Country: USA

Publications

  1. ncbi request reprint Optimal allocation of resources across four interventions for type 2 diabetes
    Stephanie R Earnshaw
    RTI Health Solutions, RTI, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Med Decis Making 22:S80-91. 2002
  2. ncbi request reprint Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates
    S R Earnshaw
    RTI Health Solutions, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Curr Med Res Opin 23:2517-29. 2007
  3. pmc Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina, USA
    J Am Soc Nephrol 19:1807-16. 2008
  4. doi request reprint Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges
    Stephanie R Earnshaw
    RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC 27709 2194, USA
    Pharmacoeconomics 31:289-304. 2013
  5. pmc Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Stephanie R Earnshaw
    RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
    BMC Infect Dis 12:101. 2012
  6. doi request reprint Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United kingdom
    Stephanie R Earnshaw
    RTI Health Solutions, 200 Park Offices Dr, Research Triangle Park, NC 27709, USA
    Clin Ther 34:1544-58. 2012
  7. doi request reprint Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis
    Stephanie R Earnshaw
    RTI Health Solutions, NC 27709, USA
    Stroke 40:1710-20. 2009
  8. doi request reprint Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Appl Health Econ Health Policy 7:91-108. 2009
  9. doi request reprint Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
    Value Health 12:507-20. 2009
  10. doi request reprint Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis
    S R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC 27709, USA
    Aliment Pharmacol Ther 31:911-21. 2010

Detail Information

Publications20

  1. ncbi request reprint Optimal allocation of resources across four interventions for type 2 diabetes
    Stephanie R Earnshaw
    RTI Health Solutions, RTI, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Med Decis Making 22:S80-91. 2002
    ..The interventions are intensive glycemic control, intensified hypertension control, cholesterol reduction, and smoking cessation...
  2. ncbi request reprint Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates
    S R Earnshaw
    RTI Health Solutions, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Curr Med Res Opin 23:2517-29. 2007
    ..An oral, less frequent administration bisphosphonate provides an opportunity to improve persistence, a parameter not well modeled in previous cost-effectiveness analyses of osteoporosis therapies...
  3. pmc Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina, USA
    J Am Soc Nephrol 19:1807-16. 2008
    ....
  4. doi request reprint Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges
    Stephanie R Earnshaw
    RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC 27709 2194, USA
    Pharmacoeconomics 31:289-304. 2013
    ..This understanding allows us to provide recommendations for using decision modelling in future economic evaluations of chemoprevention for PCa...
  5. pmc Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Stephanie R Earnshaw
    RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
    BMC Infect Dis 12:101. 2012
    ..We examined public health and economic impacts of a PCV10 and PCV13 pediatric national immunization programs (NIPs) in Canada...
  6. doi request reprint Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United kingdom
    Stephanie R Earnshaw
    RTI Health Solutions, 200 Park Offices Dr, Research Triangle Park, NC 27709, USA
    Clin Ther 34:1544-58. 2012
    ..However, trade-offs in terms of administration time and cost may affect the value of using these diagnostic studies...
  7. doi request reprint Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis
    Stephanie R Earnshaw
    RTI Health Solutions, NC 27709, USA
    Stroke 40:1710-20. 2009
    ..We examined the cost-effectiveness of adding penumbral-based MRI to usual computed tomography (CT)-based methods to identify patients for IV tPA treatment...
  8. doi request reprint Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Appl Health Econ Health Policy 7:91-108. 2009
    ..However, assessment of the cost effectiveness of NZ compared with other disease-modifying drugs in the presence of long-term data has been limited...
  9. doi request reprint Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
    Value Health 12:507-20. 2009
    ....
  10. doi request reprint Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis
    S R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC 27709, USA
    Aliment Pharmacol Ther 31:911-21. 2010
    ..Opioid-induced constipation is a common adverse event in patients with advanced illness and has a significant negative impact on patients' quality of life and costs...
  11. doi request reprint Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Pharmacoeconomics 28:489-505. 2010
    ..Although 5-alpha reductase inhibitors (5ARIs) have demonstrated that they reduce the risk of prostate cancer (PCa), they have not demonstrated cost effectiveness in the patient populations in which they have been examined...
  12. pmc Cost-utility of aspirin and proton pump inhibitors for primary prevention
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Arch Intern Med 171:218-25. 2011
    ..Proton pump inhibitors (PPIs) may reduce upper GI bleeding. We estimate the cost-utility of aspirin treatment with or without a PPI for coronary heart disease (CHD) prevention among men at different risks for CHD and GI bleeding...
  13. doi request reprint Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC, USA
    Respir Med 103:12-21. 2009
    ..We examine the lifetime cost-effectiveness of treatment with fluticasone propionate/salmeterol (500/50 microg) compared with no maintenance treatment in COPD in the US...
  14. ncbi request reprint Integer/linear mathematical programming models: a tool for allocating healthcare resources
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Institute, North Carolina 27709, USA
    Pharmacoeconomics 21:839-51. 2003
    ....
  15. ncbi request reprint A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia
    Stephanie R Earnshaw
    Health Economics of RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Manag Care Interface 18:36-44. 2005
    ..Amoxicillin/ clavulanate ER resulted in a higher percentage of patients cured compared with clarithromycin ER (88.7% vs. 82.4%, respectively) and lower average per-patient treatment costs (dollar 437.70 vs. dollar 548.14, respectively)...
  16. ncbi request reprint Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, NC, USA
    Stroke 37:2751-8. 2006
    ..In the current analysis, we examine the cost-effectiveness of early treatment with rFVIIa for ICH in the United States...
  17. ncbi request reprint The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgets
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolinar 27709, USA
    Manag Care Interface 19:39-45. 2006
    ..The implications for this sample health plan's budget are modest in the first year, and a reduction in costs is expected within three years owing to improved functional outcomes of patients...
  18. ncbi request reprint A linear programming model for allocating HIV prevention funds with state agencies: a pilot study
    Stephanie R Earnshaw
    RTI Health Solutions, RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
    Health Care Manag Sci 10:239-52. 2007
    ..We find that less efficient strategies, where 58% fewer infections are averted, result in significantly more equitable allocations. This tool serves as a guide for allocating funds for prevention activities...
  19. ncbi request reprint Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada
    Stephanie R Earnshaw
    RTI Health Solutions, Research Triangle Park, North Carolina, USA
    Clin Ther 29:2096-106; discussion 2094-5. 2007
    ..Currently, there are no treatments available for the other AMD subtypes. Pegaptanib sodium was the first pharmacologic therapy approved in Canada for the treatment of subfoveal wet AMD regardless of subtype...
  20. doi request reprint Allocating HIV prevention resources: a tool for state and local decision making
    Anke Richter
    Naval Postgraduate School, Monterey, CA, United States
    Health Policy 87:342-9. 2008
    ..By quantifying the impact of policy choices in terms of efficiency, cost, and distribution, the resource allocation tool makes the decision process more transparent and permits more informed choices...